Your Article Summary
See Latest ArticlesSuccessful Control of Intractable Hypoglycemia Using Rapamycin in an 86-year old man with a Pancreatic Insulin-Secreting Islet Cell Tumor and Metastases
Journal of Clinical Endocrinology and Metabolism, 07/02/09
Bourcier ME et al. - Rapamycin may provide a useful means of abrogating tumor growth and controlling hypoglycemia in malignant insulinomas by reducing the malignant beta cell growth and proliferation as well as inhibiting insulin production.
Related Articles
How Punctual Ablation of Regulatory T Cells Unleashes an Autoimmune Lesion within the Pancreatic Islets
Immunity, 10/27/09
Relevance Score: 81%
Transgenic Expression of Hsc70 in Pancreatic Islets Enhances Autoimmune Diabetes in Response to [beta] Cell Damage
Journal of Immunology, 10/27/09
Relevance Score: 81%
Is Antigen Specificity of Autoreactive T Cells the Key to Islet Entry
Immunity, 10/16/09
Relevance Score: 81%
Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, [alpha] Cell Hyperplasia, and Islet Cell Tumor
Pancreas, 10/26/09
Relevance Score: 80%
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression
Oncogene, 10/01/09
Relevance Score: 80%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09